Similar Search Results

Genetically modified organisms, consumer scepticism and trade law: implications for the organisation of international supply chains

Kerr, William A. - In: Supply Chain Management: An International Journal 4 (1999) 2, pp. 67-74

Given the rapid rates of technological improvements possible, using modern biotechnology, the product life cycle of new …

Persistent link: https://www.econbiz.de/10015008803

Fusing biotechnology and product innovation

In: Strategic Direction 18 (2002) 5, pp. 25-27

Recent years have seen the market opportunity for innovative bioscience products grow rapidly. For instance, the human clinical diagnostics field is now a $17 billion world‐wide market, and in specific sectors, such as point of care (POC) and over the counter (OTC), there is an increasing...

Persistent link: https://www.econbiz.de/10015009578

Winning innovation

In: Strategic Direction 19 (2003) 9, pp. 30-32

Despite the desperate general state of the UK’s engineering and manufacturing industry, great engineering innovation is still happening. This has again been highlighted by the diverse nature of the innovations from the four finalists for the 2003 MacRobert Award. Initiated in 1969, The Royal...

Persistent link: https://www.econbiz.de/10015009647

Innovations: Becoming wise to biotechnology

In: Strategic Direction 19 (2003) 11, pp. 30-32

Biotechnology has been described as a pervasive and disruptive technology. Pervasive in the sheer number of industries …

Persistent link: https://www.econbiz.de/10015009667

Leading Europe in biotechnology

In: Strategic Direction 21 (2005) 8, pp. 30-32

innovation and so better compete in the global economy, biotechnology is seen as an increasing vital sector. It is therefore good … news that despite a global slowdown, and severe “bloodletting”, a recent report confirms that the UK's biotechnology sector …

Persistent link: https://www.econbiz.de/10015009939

Technology pioneers

In: Strategic Direction 25 (2009) 4, pp. 32-34

biotechnology/health. The range of companies awarded the title is extremely diverse and includes; Canadian based BioMedica, which …

Persistent link: https://www.econbiz.de/10015010376

US prepares to expect the unexpected

In: Strategic Direction 25 (2009) 9, pp. 16-18

Purpose – Reviews the latest management developments across the globe and pinpoints practical implications from cutting‐edge research and case studies. Design/methodology/approach – This briefing is prepared by an independent writer who adds their own impartial comments and places the...

Persistent link: https://www.econbiz.de/10015010425

Aligning an R&D portfolio with corporate strategy

In: Strategic Direction 25 (2009) 2

Persistent link: https://www.econbiz.de/10015011329

Innovation through M&A in the biopharmaceutical sector

Amir-Aslani, Arsia; Chanel, Mark Anthony - In: Strategic Direction 32 (2016) 6, pp. 27-29

Purpose This paper aims to review the latest management developments across the globe and pinpoint practical implications from cutting-edge research and case studies. Design/methodology/approach This briefing is prepared by an independent writer who adds their own impartial comments and places...

Persistent link: https://www.econbiz.de/10015012234

Cross-Border M&A is followed by cross-border investor relations

Amir-Aslani, Arsia; Lê, Philippe; Chanel, Mark Anthony - In: Strategic Direction 32 (2016) 9, pp. 4-6

and their short/term goals has not been extensively covered for the biotechnology sector. …

Persistent link: https://www.econbiz.de/10015012511